Nickle Steven Brandon, Peterson Nathan, Peterson Michael
Broward Medical Center, Fort Lauderdale, Florida;
Aspen Dermatology Residency Program, Spanish Fork, Utah;
J Clin Aesthet Dermatol. 2014 Apr;7(4):22-34.
While oral isotretinoin is renowned for its ability to treat acne vulgaris, many of its off-label uses continue to go underappreciated. Since the last review on the unapproved indications of isotretinoin, relevant publications have surfaced with new recommendations. This article attempts to provide physicians with the latest information regarding successful and unsuccessful use of isotretinoin as an effective treatment for dermatological conditions, such as rosacea, psoriasis, pityriasis rubra pilaris, condyloma acuminatum, granuloma annulare, Darier's disease, systemic cutaneous lupus erythematosus, nonmelanoma skin cancer, and hidradenitis suppurativa. Variations in dosage regimens and isotretinoin viability as an alternative to other standard treatments are also discussed in relation to these conditions.
虽然口服异维A酸因其治疗寻常痤疮的能力而闻名,但其许多非标签用途仍未得到充分重视。自上次对异维A酸未获批适应症进行综述以来,出现了一些有新建议的相关出版物。本文旨在为医生提供有关异维A酸成功和不成功用于治疗各种皮肤病(如玫瑰痤疮、银屑病、毛发红糠疹、尖锐湿疣、环状肉芽肿、 Darier病、系统性皮肤红斑狼疮、非黑色素瘤皮肤癌和化脓性汗腺炎)的最新信息。还讨论了与这些病症相关的剂量方案变化以及异维A酸作为其他标准治疗替代方案的可行性。